NCT06344195View on ClinicalTrials.gov

Valacyclovir Monotherapy in Pain Management of Acute Periapical Abscesses After Emergency Chamber Opening

PHASE4RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 27, 2024

Primary Completion Date

April 30, 2024

Study Completion Date

May 31, 2024

Conditions

Acute Apical Abscess

Interventions

DRUG

Valacyclovir 500 mg

Valtrex 2g immediate dose followed by 500mg 2 times daily for 3 days along with the analgesic (SOS, if needed) for 6 days

DRUG

Naproxen Sodium 550mg

550mg (as needed, SOS) for 6 days

Trial Locations (1)

75290

RECRUITING

Dr. Yumna Shaheen Ali, Karachi

All Listed Sponsors

lead

Dow University of Health Sciences

OTHER

NCT06344195 - Valacyclovir Monotherapy in Pain Management of Acute Periapical Abscesses After Emergency Chamber Opening | Biotech Hunter | Biotech Hunter